These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9304673)
21. Health insurance theory: the case of the missing welfare gain. Nyman JA Eur J Health Econ; 2008 Nov; 9(4):369-80. PubMed ID: 18058142 [TBL] [Abstract][Full Text] [Related]
22. Pricing implications of trends in population mortality and underwriting effectiveness. Pokorski RJ J Insur Med; 2004; 36(1):54-9. PubMed ID: 15104030 [TBL] [Abstract][Full Text] [Related]
23. Flunk the gene test and lose your insurance. Cowley G Newsweek; 1996 Dec; 128(26):48-50. PubMed ID: 10163863 [No Abstract] [Full Text] [Related]
24. Genetic testing and insurance. Bodmer W Nature; 1996 Apr; 380(6573):384-6. PubMed ID: 8602232 [No Abstract] [Full Text] [Related]
25. Insurance industry executive address. Where do we draw the line? Wheeler TB Trans Am Acad Insur Med; 1993; 76():10-7. PubMed ID: 8337764 [No Abstract] [Full Text] [Related]
26. Genetic Catch-22: testing, risk and private health insurance. Hedgecoe A Bus Prof Ethics J; 1996; 15(2):69-86. PubMed ID: 11655327 [No Abstract] [Full Text] [Related]
27. Will new therapy for genetic disease alter underwriting practices? Desnick R J Insur Med; 1993; Suppl B():247-51. PubMed ID: 10146360 [No Abstract] [Full Text] [Related]
28. Adverse selection and price sensitivity when low-income people have subsidies to purchase health insurance in the private market. Swartz K; Garnick DW Inquiry; 2000; 37(1):45-60. PubMed ID: 10892357 [TBL] [Abstract][Full Text] [Related]
30. How did welfare reform affect the health insurance coverage of women and children? Cawley J; Schroeder M; Simon KI Health Serv Res; 2006 Apr; 41(2):486-506. PubMed ID: 16584461 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk factors, BMI and mortality in a cohort of Swiss males (1976-2001) with high-sum-assured life insurance cover. Baldinger B; Schwarz C; Jaggy C J Insur Med; 2006; 38(1):44-53. PubMed ID: 16642642 [TBL] [Abstract][Full Text] [Related]
32. Selected transactions of the International Underwriting Congress 1997. Medical underwriting in the genetics era. Pokorski RJ J Insur Med; 1997; 29(2):107-19. PubMed ID: 10169628 [No Abstract] [Full Text] [Related]
33. The impact of genetics on medical underwriting. Lowden JA Trans Am Acad Insur Med; 1993; 76():115-24. PubMed ID: 8337765 [No Abstract] [Full Text] [Related]
34. Should insurance pay for preventive services suggested by genetics? Lawrence J Manag Care; 1997 Jan; 6(1):42-6. PubMed ID: 10164532 [TBL] [Abstract][Full Text] [Related]
35. A look at the possible impact of new genetic technology on the life insurance industry. Necessary P J Insur Med; 1995-1996 Winter; 27(3):207-13. PubMed ID: 10160223 [No Abstract] [Full Text] [Related]
36. Why not rate health and life insurance by risks? N Engl J Med; 1983 Jul; 309(4):246-7. PubMed ID: 6866050 [No Abstract] [Full Text] [Related]
37. Genetic tests for many rare diseases headed for orphan status. Kuska B J Natl Cancer Inst; 1997 Dec; 89(23):1748-9. PubMed ID: 9392610 [No Abstract] [Full Text] [Related]
38. Disclosures of retiree health benefits liabilities. Employee Benefit Plan Rev; 1986 Nov; 41(5):8, 12, 14. PubMed ID: 10279622 [No Abstract] [Full Text] [Related]
39. Genetic testing and insurance in Australia. Otlowski M; Barlow-Stewart K; Lacaze P; Tiller J Aust J Gen Pract; 2019 Mar; 48(3):96-99. PubMed ID: 31256467 [TBL] [Abstract][Full Text] [Related]
40. The use of genetic information for nonmedical purposes. Rothstein MA J Law Health; 1994-1995; 9(1):109-20. PubMed ID: 11654452 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]